Summary of Study ST001247

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000834. The data can be accessed directly via it's Project DOI: 10.21228/M8W67P This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001247
Study TitleLongitudinal Characterization of the Fecal Metabolome in Dogs with Idiopathic Inflammatory Bowel Disease
Study SummaryThirteen dogs diagnosed with idiopathic IBD, that previously failed to respond to treatment with elimination diets and metronidazole, were enrolled. Stool samples were collected from all dogs before initiating therapy with prednisone, after 3 and 8 weeks, and more than one year after beginning treatment. Thirteen healthy dogs were enrolled in the study as a control group.
Institute
Texas A&M University
DepartmentDepartment of Small Animal Clinical Sciences
LaboratoryGastrointestinal Laboratory
Last NamePilla
First NameRachel
Address4474 TAMU
Emailrpilla@cvm.tamu.edu
Phone9798622861
Submit Date2019-09-03
Raw Data AvailableYes
Raw Data File Type(s)cdf
Analysis Type DetailMALDI-MS
Release Date2020-06-03
Release Version1
Rachel Pilla Rachel Pilla
https://dx.doi.org/10.21228/M8W67P
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Mammal; Subject species: Canis lupus familiaris (Factor headings shown in green)

mb_sample_id local_sample_id Time point Status Treatment
SA090839Healthy_19_0720WK HC none
SA090840Healthy_18_0710WK HC none
SA090841Healthy_20_0730WK HC none
SA090842Healthy_22_0740WK HC none
SA090843Healthy_23_0750WK HC none
SA090844Healthy_12_0700WK HC none
SA090845Healthy_01_0640WK HC none
SA090846Healthy_06_0680WK HC none
SA090847Healthy_05_0670WK HC none
SA090848Healthy_04_0660WK HC none
SA090849Healthy_02_0650WK HC none
SA090850Healthy_25_0760WK HC none
SA090851Healthy_07_0690WK HC none
SA090852BL_placebo_23_0070WK IBD none
SA090853BL_placebo_28_0080WK IBD none
SA090854BL_placebo_20_0060WK IBD none
SA090855BL_placebo_19_0050WK IBD none
SA090856BL_placebo_11_0030WK IBD none
SA090857BL_placebo_14_0040WK IBD none
SA090858BL_placebo_04_0010WK IBD none
SA090859BL_placebo_35_0090WK IBD none
SA090860BL_placebo_07_0020WK IBD none
SA090861LT_placebo_14_0531YR IBD none
SA090862LT_placebo_23_0551YR IBD none
SA090863LT_placebo_28_0561YR IBD none
SA090864LT_placebo_11_0521YR IBD none
SA090865LT_placebo_19_0541YR IBD none
SA0908663WK_placebo_35_0263WK IBD prednisone
SA0908673WK_placebo_28_0253WK IBD prednisone
SA0908683WK_placebo_23_0243WK IBD prednisone
SA0908693WK_placebo_07_0193WK IBD prednisone
SA0908703WK_placebo_19_0223WK IBD prednisone
SA0908713WK_placebo_11_0203WK IBD prednisone
SA0908723WK_placebo_20_0233WK IBD prednisone
SA0908733WK_placebo_04_0183WK IBD prednisone
SA0908743WK_placebo_14_0213WK IBD prednisone
SA0908758WK_placebo_19_0398WK IBD prednisone
SA0908768WK_placebo_11_0378WK IBD prednisone
SA0908778WK_placebo_07_0368WK IBD prednisone
SA0908788WK_placebo_04_0358WK IBD prednisone
SA0908798WK_placebo_14_0388WK IBD prednisone
SA0908808WK_placebo_20_0408WK IBD prednisone
SA0908818WK_placebo_28_0428WK IBD prednisone
SA0908828WK_placebo_23_0418WK IBD prednisone
SA0908838WK_placebo_35_0438WK IBD prednisone
Showing results 1 to 45 of 45
  logo